In vivo augmentation of natural killer cell activity with a deoxyribonucleic acid fraction of bcg

Japanese Journal of Cancer Research GANN

Volumn 77, Issue 8, 1986, Pages 808-816

  Shimada, Shizuo ^a   Yano, Osamu ^a   Tokunaga, Tohru ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

BCG; Biological response modifier; DNA; Natural killer cell

Indexed keywords

BCG VACCINE; CARBONYL IRON; CARRAGEENAN; COMPLEMENT; DEOXYRIBONUCLEASE; DNA; RIBONUCLEASE;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; BCG VACCINE DERIVATIVE; BIOLOGICAL RESPONSE; CANCER CHEMOTHERAPY; DRUG ANTAGONISM; DRUG COMPARISON; DRUG PURIFICATION; DRUG SCREENING; GANGLIOTETRAOSYLCERAMIDE ANTIBODY; HISTOLOGY; IN VITRO STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PERITONEUM; PRIORITY JOURNAL; SERUM; THERAPY; THY 1.2 ANTIGEN;

ANIMAL; CARRAGEENAN; CYTOTOXICITY, IMMUNOLOGIC; DEOXYRIBONUCLEASES; DNA; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FEMALE; GLYCOSPHINGOLIPIDS; KILLER CELLS, NATURAL; MICE; MICE, INBRED STRAINS; MYCOBACTERIUM BOVIS; NEOPLASMS, EXPERIMENTAL; PERITONEAL CAVITY; RIBONUCLEASES; RNA; SUPPORT, NON-U.S. GOV'T;

EID: 0022544031     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Tokunaga, T., Yamamoto, H., Shimada, S., Abe, H., Fukuda, T., Fujisawa, Y., Furutani, Y., Yano, O., Kataoka, T., Sudo, T., Makiguchi, N. and Suganuma, T. Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicoehemical characterization and antitumor activity. J. Natl. Cancer Inst., 72, 955–962 (1984).
2. Shimada, S., Yono, O., Inoue, H., Kura-moto, E., Fukuda, T., Yamamoto, H., Kataoka, T. and Tokunaga, T. Antitumor activity of the DNA fraction from Mycobac-terium bovis BCG. II. Effects on various syngeneic mouse tumors. J. Natl. Cancer Inst., 74, 681–688 (1985).
3. Kasai, M., Iwamori, M., Nagai, Y., Okumura, K. and Tada, T. A glycolipid on the surface of mouse natural killer cells. Eur. J. Immunol., 10, 175–180 (1980).
4. Taki, T., Hirabayashi, Y., Takagi, K., Kamada, R., Kojima, K. and Matsumoto, M. Purification of anti-glycosphingolipid antibody and topological localization of glycosphingolipid on the cell surface of rat ascites hepatomas. J. Biochem., 89, 503–510 (1981).
5. Kumagai, K., Itoh, K., Suzuki, R., Hinuma, S. and Saitoh, F. Studies of murine large granular lymphocytes. I. Identification as effector cells in NK, and K cytotoxicities. J. Immunol., 129, 388–394 (1982).
6. Watson, J. and Riblet, R. Genetic control of responses to bacterial lipopolysaccharides in mice. I. Evidence for a single gene that influences mitogenic and immunogenic responses to lipopolysaccharides. J. Exp. Med., 140, 1147–1161 (1974).
7. Ehrlich, R., Efrati, M. and Witz, I. P. Further studies on the cytostatic activity mediated by murine splenocytes. In “NK Cells and Other Natural Effector Cells,” ed. R. B. Herberman, pp. 201–208 (1982). Academic Press, New York.
8. Herberman, R. B., Nunn, M. E. and Lavrin, D. H. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. I. Distribution of reactivity and specificity. Int. J. Cancer, 16, 216–229 (1975).
9. Kiessling, R., Klein, E. and Wigzell, H. “Natural” killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur. J. Immunol., 5, 112–117 (1975).
10. Young, W. W., Jr., Hakomori, S., Durdik, J. M. and Henney, C. S. Identification of ganglio-N-tetraosylceramide as a new cell surface marker for murine natural killer (NK) cells. J. Immunol, 124, 199–201 (1980).
11. Akagawa, K. S. and Tokunaga, T. Ap-pearance of a cell surface antigen associated with the activation of peritoneal macro-phages in mice. Microbiol. Immunol., 26, 831–842 (1982).
12. Durdik, J. M., Beck, B. N. and Henney, C. S. Asialo GM1 and Thy 1 as cell surface markers of murine NK cells. In “Natural Cell-mediated Immunity against Tumors,” ed. R. B. Herberman, pp. 37–46 (1980). Academic Press, New York.
13. Djeu, J. Y., Heinbaugh, J. A., Holden, H. T. and Herberman, R. B. Augmentation of mouse natural killer activity by interferon and interferon inducers. J. Immunol., 122, 175–181 (1979).
14. Kasai, M., Yoneda, T., Habu, S., Maru-yama, Y., Okumura, K. and Tokunaga, T. In vivo effect of anti-asialo GM1 antibody on natural killer activity. Nature, 291, 334–335 (1981).
15. LeBlanc, P. A. and Russel, S. W. Depletion of mononuclear phagocytes: pitfalls in the use of carbonyl iron, carrageenan, silica, trypan blue, or antimononuclear phagocyte serum. In “Methods for Studying Mononu-clear Phagocytes,” ed. D. O. Adams, P. J. Edelson and H. S. Koren, pp. 231–242 (1981). Academic Press, New York.
16. Djeu, J. Y., Heinbaugh, J. A., Holden, H. T. and Herberman, R. B. Role of macrophages in the augmentation of mouse natural killer cell activity by poly I: C and interferon. J. Immunol, 122, 162–188 (1979).
17. Kasai, M., Leclerc, J. C., MacVay-Boudreau, L., Shen, F. W. and Cantor, H. Direct evidence that natural killer cells in nonimmune spleen cell populations pre-vent tumor growth in vivo. J. Exp. Med., 149, 1260–1264 (1979).
18. Talmadge, J. E., Meyers, K. M., Prieur, D. J. and Starkey, J. R. Role of NK cells in tumour growth and metastasis in beige mice. Nature, 284, 622–624 (1980).
19. Karre, K., Klein, G. O., Kiessling, R., Klein, G. and Roder, J. C. Low natural in vivo resistance to syngeneic leukaemias in natural killer-deficient mice. Nature, 284, 624–626 (1980).
20. Hanna, N. and Burton, R. C. Definitive evidence that natural killer (NK) cells inhibit experimental tumor metastasis in vivo. J. Immunol, 127, 1754–1758 (1981).
21. Warner, J. F. and Dennert, G. Effects of a cloned cell line with NK activity on bone marrow transplants, tumour development and metastasis in vivo. Nature, 300, 31–34 (1982).
22. Wolfe, S. A., Tracey, D. E. and Henney, C. S. Induction of “natural killer” cells by BCG. Nature, 262, 584–586 (1976).
23. Tokunaga, T., Shimada, S. and Yamamoto, S. Biologic response to DNA extracted from BCG and to synthetic DNA. Int. J. Immunopharmacol, 7, 301 (1985).